Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- KR7095700001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Manufacturing
Description
Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-12 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2022-12-08 00:00 |
[기재정정]주요사항보고서(유무상증자결정)
|
Korean | 37.4 KB | ||
| 2022-12-08 00:00 |
[기재정정]증권신고서(지분증권) (2022.12)
|
Korean | 2.6 MB | ||
| 2022-12-08 00:00 |
[기재정정]투자설명서
|
Korean | 2.6 MB | ||
| 2022-12-07 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.0 KB | ||
| 2022-12-05 00:00 |
[기재정정]주요사항보고서(유무상증자결정)
|
Korean | 38.6 KB | ||
| 2022-12-05 00:00 |
[기재정정]증권신고서(지분증권) (2022.12)
|
Korean | 2.6 MB | ||
| 2022-12-05 00:00 |
[기재정정]투자설명서
|
Korean | 2.6 MB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2022-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.3 KB | ||
| 2022-11-18 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 10.1 KB |
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genexine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
